Ask an Expert

Question of the Day

Bryan L. Roth, M.D., Ph.D.
September 16, 2011

I’m reminded on a daily basis how far we’ve come and yet how far we need to go to effectively treat schizophrenia and related disorders. I feel daily tremendous gratitude for the newer medications and have seen first-hand how miraculous the recoveries can be. On the other hand, I’m also a witness to the devastation effected by negative symptoms and cognitive deficits for which we have nothing, yet, of lasting benefit. I remain hopeful that technologies my lab and others have developed will point the way towards more comprehensive treatment strategies for schizophrenia and similar disorders.

Bryan L. Roth, M.D., Ph.D.
Scientific Council Member
Michael Hooker Distinguished Professor
Director, NIMH Psychoactive Drug Screening Program
University of North Carolina Chapel Hill Medical School

Judith L. Rapoport, M.D. - Brain & behavior research expert on schizophrenia
Q Is there any way to prevent suspect genes from causing mental illness or to prevent the development of these 'copy-number variants' (CNVs) that have been linked to schizophrenia? Is that a current focus of research?
A So far, there is no known way to stop copy number variants (CNVs) from... More >
Jeffrey A. Lieberman, M.D., Columbia University Medical Center
Q Where will the breakthroughs come in treating schizophrenia?
A “The single biggest thing that would aid research in mental illnesses and... More >